← Leaderboards
Maria Fernanda Carrera Rodriguez
University Of Pennsylvania
$96,668
Attributed
$96,668
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49K · FY2023–24$50K$37.5K$25K$12.5K$0
'23
'24
Funding mix
By agency
NIH$96,668 · 1
By mechanism
F31$96,668 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Xianxin Hua$10,319,732
- Jennifer L Morse$2,699,432
- Bryson William Katona$1,478,445
- Brian Capell$2,783,810
- Christos Davatzikos$42,474,609
Others in their field
Other Rising Stars on “Acute Myelocytic Leukemia”
- Michael E. Roth · Public Health Institute$8,303,012
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Kellie Bickel · Twinstrand Biosciences, Inc.$2,555,383
- Jeevisha Bajaj · University Of Rochester$2,438,184
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Angela Goffredo Fleischman · University Of California-Irvine$2,306,090
Research focus
Acute Myelocytic LeukemiaAcute Myeloid Leukemia CellAdoptedAutomobile DrivingBloodCd86 GeneCell CycleCell Differentiation ProcessCell ModelCellsCellular AssayCessation Of LifeCharacteristicsChemotherapyChip-SeqChromatinClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsCofactorCohortCombinatorialCombinatoricsCombined Modality TherapyAccounting
Grant awards (2)
Differentiation-focused CRISPR Screen identifies LSD1 and Menin as combination therapy targets that induce terminal differentiation in AML$48,974
F31 · FY2024 · CA · contact PI
Differentiation-focused CRISPR Screen identifies LSD1 and Menin as combination therapy targets that induce terminal differentiation in AML$47,694
F31 · FY2023 · CA · contact PI